Özlem Türeci
Oprichter bij BIONTECH SE
Vermogen: 79 M $ op 30-04-2024
Actieve functies van Özlem Türeci
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| BIONTECH SE | Hoofd Techniek/Wetenschap/O&O | 01-01-2018 | - |
| Oprichter | 02-06-2008 | - | |
| Association For Cancer Immunotherapy | President | - | - |
| Directeur/Bestuurslid | - | - | |
| Ci3 Management UG | Voorzitter | - | - |
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
 Universitätsmedizin der Johannes Gutenberg-Universität Mainz Medical/Nursing ServicesHealth Services Universitätsmedizin der Johannes Gutenberg-Universität Mainz KöR owns and operates medical institutions and clinics. It offers nursing and optimal patient care, diagnostic, care management, and other related healthcare services. The company is headquartered in Mainz, Germany. | Corporate Officer/Principal | - | - |
Loopbaan van Özlem Türeci
Eerdere bekende functies van Özlem Türeci
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Ganymed Pharmaceuticals AG
 Ganymed Pharmaceuticals AG BiotechnologyHealth Technology Ganymed Pharmaceuticals AG develops antibodies for the treatment of solid cancers. It focuses on developing ideal monoclonal antibodies that include cancer-selective targets for maximal high-precision anticancer potency, as well as mitigates the threat of toxicity. The company was founded by Özlem Türeci, Dirk L. Sebastian, Christoph Huber and Ugur Sahin in 2001 and is headquartered in Mainz, Germany. | Algemeen Directeur | 01-01-2008 | - |
| Hoofd Techniek/Wetenschap/O&O | 01-01-2001 | - | |
| Oprichter | 01-01-2001 | - |
Opleiding van Özlem Türeci
| Universität des Saarlandes | Undergraduate Degree |
Statistieken
Internationaal
| Duitsland | 7 |
Operationeel
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 2 |
| Chief Executive Officer | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 2 |
| Health Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| BIONTECH SE | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Ganymed Pharmaceuticals AG
Ganymed Pharmaceuticals AG BiotechnologyHealth Technology Ganymed Pharmaceuticals AG develops antibodies for the treatment of solid cancers. It focuses on developing ideal monoclonal antibodies that include cancer-selective targets for maximal high-precision anticancer potency, as well as mitigates the threat of toxicity. The company was founded by Özlem Türeci, Dirk L. Sebastian, Christoph Huber and Ugur Sahin in 2001 and is headquartered in Mainz, Germany. | Health Technology |
| Association For Cancer Immunotherapy | |
| Ci3 Management UG | |
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Universitätsmedizin der Johannes Gutenberg-Universität Mainz Medical/Nursing ServicesHealth Services Universitätsmedizin der Johannes Gutenberg-Universität Mainz KöR owns and operates medical institutions and clinics. It offers nursing and optimal patient care, diagnostic, care management, and other related healthcare services. The company is headquartered in Mainz, Germany. | Health Services |
- Beurs
- Insiders
- Özlem Türeci
- Ervaring